Structural Bioinformatics Pens Protein Structure Deal with RW Johnson | GenomeWeb

NEW YORK, Jan 25 – Structural Bioinformatics said Thursday that it had reached a deal to “elucidate” protein structures for The RW Johnson Pharmaceutical Research Institute, a subsidiary of Johnson & Johnson.

“We are extremely pleased to begin a relationship with The R.W. Johnson
Pharmaceutical Research Institute on target structure elucidation,” Edward Maggio, CEO of SBI, said in a statement.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.